Change of Manufacturing Location

E

elleseo

#1
Hello,

Our company is preparing a dossier for getting CE mark.
Let me give you detail situation.

There are two facilities (A, B (x 7 times scale up) and the distance is only 20 minutes by a car.
Our product is classified to Class III, but is not registred.
We conducted a clinical trial to support our indication and several non-clinical testings with a product from the facility A (There is no clinical/nonclinical data from the facility B). A couple of the non-chlinical tests are not satisfied the MD regulation.
All validations related the process, quality will be done in the facility B.

Here are my basic questions.
Our company will be register the facility B for commercical products.
For this, we will filed all data, CMC, clinical/non-clinical data in facility A and stability data in facility B. In addition, the equivalent data (manufacturing process and quality) between two facilities will be included.

Question No.1
The non-clinical tests not meet to the regulation will be included after doing new tests with the product manufactured from the facility B in case of we verify the equivalance.
Will it be possible for registration as a regulatory aspect?
Do we have to do the non-clinical tests with the product produced from the facility A?

Question No.2
What is the best way to register our product using all data we have?
I know some tests must be performed, but I don't think the clinical test will be not.

I hope you can help me a lot.
Thanks.

Elleseo
 
Elsmar Forum Sponsor

somashekar

Staff member
Super Moderator
#2
Hi Eelleseo.
Thanks for your good question and welcome to the Cove.
While someone expert with the EU regulations will pitch in, my advice to you is to open up all your questions with your NB.... for your NB is the one who provides the gateway to the EU with the CE mark.
 
E

elleseo

#3
Thanks for your reply.
You are right, but our NB is not a good responsor. It takes too long to give us the reponse to us.
 

RobertvanBoxtel

Involved In Discussions
#4
Best approach (as indicated to be followed by you):
Identify for each tests which products (from what site) are used.
Demonstrate through testing which ER is covered (or more)
In case product tested comes from A, argue how it covers the final design specifications. Same applies to products tested from site B.

In case you need more detailed guidance, I am afraid you need to provide more detailed information.
 

RobertvanBoxtel

Involved In Discussions
#6
Transferring from one site to the other requires a lot of evidence to demonstrate continuous control.
And to be able to demonstrate something, yes, documentation is needed. Because if you cannot demonstrte it on paper (or electronically), it ain't done...
 

pkost

Trusted Information Resource
#7
My thoughts on this are as follows:

the locations of manufacture are somewhat irrelevant at this stage as the device is not approved; you must be able to show/prove (and this is no different from if you were using the same site):

1. The products you manufacture for the clinical study at site A are as intended by the design specification (otherwise how you you prove the design is safe/effective)
2. Your device that is manufactured as intended by the design spec is safe and effective (this is the purpose of the clinical evaluation
3. The product you manufacture at the main production site (B) comply with the design specification that was used as part of the clinical evaluation (i.e. the product continues to be safe and effective)

The main concern of the notified body will be "how do you know that product produced at site B is the same as the product at site A"

Things to consider (this is not a complete list)
- are all components sourced from the same place, do they go through the same or more rigorous inspection checks
- are all the in process controls the same (or more rigorous)
- is the batch release criteria the same?
- is packaging the same specification
- is the sterility still assured?
- is equipment calibrated to the necessary level
 
Thread starter Similar threads Forum Replies Date
N Is a new 510K required for change of manufacturing location for an existing device? US Food and Drug Administration (FDA) 1
M Change in Manufacturing, Assembly and Testing Location to a Sub-Contractor 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 6
S Medical Devices - Change of Manufacturing Location US Food and Drug Administration (FDA) 5
R Medical Device - Change manufacturing plant Design and Development of Products and Processes 6
Q Legal Manufacturing Address Change – multiple registrations at same address 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
N China - Start manufacturing before change approval? China Medical Device Regulations 3
B Manufacturing Company Address Change - implications for FDA Other US Medical Device Regulations 1
M FDA News USFDA Final Guidance – Manufacturing Site Change Supplements: Content and Submission Medical Device and FDA Regulations and Standards News 1
Ajit Basrur FDA News FDA Guidance Document: Manufacturing Site Change Supplement US Food and Drug Administration (FDA) 0
S Change notice while switching to injection molding technique for manufacturing EU Medical Device Regulations 1
H FDA/PMA/Medical Device/Before submission/Manufacturing facility change US Food and Drug Administration (FDA) 1
J How to change the Manufacturing Site to another Contract Manufacturer Japan Medical Device Regulations 1
V Product Evaluation Requirements for Change in Manufacturing Facility/Change in Design 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 12
T Initiating Cultural Change in a Small Manufacturing Company Quality Manager and Management Related Issues 4
D AS9100 Scope Change to Include Manufacturing Services AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 5
A Temporary Change of Manufacturing Site - Notified Body Notification Requirements EU Medical Device Regulations 3
K Need help with AS9100 Scope Change to include Manufacturing Process Maps, Process Mapping and Turtle Diagrams 1
R Change in Direction - Management decides to Outsource Manufacturing Operations ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 8
R PMA (Parts Manufacturing Approval) Supplement - Labeling Software Change 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
A Concession/ Deviation for change in manufacturing process IATF 16949 - Automotive Quality Systems Standard 1
K 8.2.3.1 Monitoring and measurement of manufacturing processes - Tool change IATF 16949 - Automotive Quality Systems Standard 5
A Lean Manufacturing - How do I change my company's Culture? Lean in Manufacturing and Service Industries 26
dgrainger Informational MHRA's Software and AI as a Medical Device Change Programme UK Medical Device Regulations 0
K Is implementing Electronic Signatures a Significant Change to the QMS? ISO 13485:2016 - Medical Device Quality Management Systems 10
A Management of change procedure for ISO 45001 Occupational Health & Safety Management Standards 3
N Cleanroom Classification Change Other Medical Device Related Standards 7
D Engineering Change order vs. Change Control ISO 13485:2016 - Medical Device Quality Management Systems 3
Watchcat Change Request Documents - What's Typical These Days? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 14
NDesouza Management of Change (MOC) Manufacturing and Related Processes 11
H Customer Specific Change in a SaaS SAMD IEC 62304 - Medical Device Software Life Cycle Processes 1
D GAMP CAT 5 Change Control Qualification and Validation (including 21 CFR Part 11) 9
lanley liao Questions regarding the change of critical suppliers and key personnel Oil and Gas Industry Standards and Regulations 5
I What revalidation is necessary if we change parts in a WFI loop ? Qualification and Validation (including 21 CFR Part 11) 1
Y Exporting data to the cloud is a "Significant Change"? EU Medical Device Regulations 5
A Design Change/ECO Related Question 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
S Reseller Request to Change UPC on Medical Device via Re-labeling Medical Device and FDA Regulations and Standards News 5
S Change management with FAA Federal Aviation Administration (FAA) Standards and Requirements 0
R Revalidation under VDmax25 following material change ISO 13485:2016 - Medical Device Quality Management Systems 2
D Change to labelling - does it require a new 510(k)? US Food and Drug Administration (FDA) 5
A How can we change a device trade name in 510(k) summary? US Food and Drug Administration (FDA) 0
L Change Notification Requirements for class 1 devices Medical Device and FDA Regulations and Standards News 1
R CB/Auditor Requiring a change in scope ISO 9000, ISO 9001, and ISO 9004 Quality Management Systems Standards 8
Ed Panek Notified Body Substantial Change MDD EU Medical Device Regulations 1
A Purchasing Controls on Change Management of Literature/Labeling ISO 13485:2016 - Medical Device Quality Management Systems 3
A For software change - New Channel of interoperability CE Marking (Conformité Européene) / CB Scheme 5
JoCam IEC 60601-1 and 60601-1-2 retest after PCBA change IEC 60601 - Medical Electrical Equipment Safety Standards Series 3
N ISO 13485 7.3.9 Change control in medical device software ISO 13485:2016 - Medical Device Quality Management Systems 6
A ISO 13485 procedure change and reflect to legacy manufacture items ISO 13485:2016 - Medical Device Quality Management Systems 2
R AS9102 FAI Change in Material / Process Supplier AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 4
D Reports under change management | ISO 13485:2016 & ISO 9001:2015 ISO 13485:2016 - Medical Device Quality Management Systems 3

Similar threads

Top Bottom